Back

The high HDL controversy continues: the prognosis for women with a high HDL profile is seriously unfavourable

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Women and specific aspect of cardiovascular disease Cardiovascular Disease in Women ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Francisco Sousa

Hospital Central do Funchal, Funchal (Portugal)

6 More presentations in this session

Presentation thumbnail
Klotho plasma levels are an independent predictorof mortality in women with acute coronary syndrome
Doctor A. Kallmeyer (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Gender differences in all-cause mortality in patients with heart failure and stroke.
Mr J. Cruz (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Sex hormones and cardiovascular disease among community-based Chinese women: a cohort study
Miss T. Wang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Risk prediction for incident hypertension following delivery using electronic health record data
Doctor J. Lewey (Philadelphia, US)
Abstract Slides Video
Presentation thumbnail
Differences between women and men with acute myocardial infarction in clinical characteristics, risk factors, and socioeconomic factors - the GENAMI Prevention Study
Doctor G. Moreno (Madrid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Women and specific aspect of cardiovascular disease

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
High levels of high-density lipoprotein cholesterol (HDL-C) and major adverse cardiovascular events and 10-year all-cause mortality:results from Women's Ischemia Syndrome Evaluation (WISE) study
thumbnail
Congress Presentation
Association of LDL cholesterol levels and all cause mortality in a real world analysis using data from an international network
thumbnail
Congress Presentation
High-sensitivity CRP to HDL-C ratio as a novel inflammatory-lipid biomarker for mortality risk prediction: a prospective population-based cohort study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources